BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36931700)

  • 1. LIM domain-containing protein Ajuba inhibits chemotherapy-induced apoptosis by negatively regulating p53 stability in colorectal cancer cells.
    Xu B; Li Q; Zhang J; Chen F
    Mol Oncol; 2023 Aug; 17(8):1678-1691. PubMed ID: 36931700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LIM protein AJUBA promotes colorectal cancer cell survival through suppression of JAK1/STAT1/IFIT2 network.
    Jia H; Song L; Cong Q; Wang J; Xu H; Chu Y; Li Q; Zhang Y; Zou X; Zhang C; Chin YE; Zhang X; Li Z; Zhu K; Wang B; Peng H; Hou Z
    Oncogene; 2017 May; 36(19):2655-2666. PubMed ID: 27893714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsa_circ_0128846 promotes tumorigenesis of colorectal cancer by sponging hsa-miR-1184 and releasing AJUBA and inactivating Hippo/YAP signalling.
    Wang X; Chen Y; Liu W; Liu T; Sun D
    J Cell Mol Med; 2020 Sep; 24(17):9908-9924. PubMed ID: 32681581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LIM protein JUB promotes epithelial-mesenchymal transition in colorectal cancer.
    Liang XH; Zhang GX; Zeng YB; Yang HF; Li WH; Liu QL; Tang YL; He WG; Huang YN; Zhang L; Yu LN; Zeng XC
    Cancer Sci; 2014 Jun; 105(6):660-6. PubMed ID: 24673742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ajuba overexpression regulates mitochondrial potential and glucose uptake through YAP/Bcl-xL/GLUT1 in human gastric cancer.
    Li H; Fu L; Liu B; Lin X; Dong Q; Wang E
    Gene; 2019 Apr; 693():16-24. PubMed ID: 30690182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ajuba transactivates N-cadherin expression in colorectal cancer cells through interaction with Twist.
    Wu Z; Zou X; Xu Y; Zhou F; Kuai R; Li J; Yang D; Chu Y; Peng H
    J Cell Mol Med; 2021 Aug; 25(16):8006-8014. PubMed ID: 34173718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The LIM protein Ajuba/SP1 complex forms a feed forward loop to induce SP1 target genes and promote pancreatic cancer cell proliferation.
    Zhang B; Song L; Cai J; Li L; Xu H; Li M; Wang J; Shi M; Chen H; Jia H; Hou Z
    J Exp Clin Cancer Res; 2019 May; 38(1):205. PubMed ID: 31101117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
    Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
    Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGA2 promotes intestinal tumorigenesis by facilitating MDM2-mediated ubiquitination and degradation of p53.
    Wang Y; Hu L; Wang J; Li X; Sahengbieke S; Wu J; Lai M
    J Pathol; 2018 Dec; 246(4):508-518. PubMed ID: 30175854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophilin B induces chemoresistance by degrading wild-type p53 via interaction with MDM2 in colorectal cancer.
    Choi TG; Nguyen MN; Kim J; Jo YH; Jang M; Nguyen NNY; Yun HR; Choe W; Kang I; Ha J; Tang DG; Kim SS
    J Pathol; 2018 Sep; 246(1):115-126. PubMed ID: 29876924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance.
    Zhou S; Lu J; Li Y; Chen C; Cai Y; Tan G; Peng Z; Zhang Z; Dong Z; Kang T; Tang F
    J Exp Clin Cancer Res; 2018 Nov; 37(1):284. PubMed ID: 30477538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic antiprotozoal thiazolide drug induced apoptosis in colorectal cancer cells: implications of IL-6/JAK2/STAT3 and p53/caspases-dependent signaling pathways based on molecular docking and in vitro study.
    Tantawy MA; El-Sherbeeny NA; Helmi N; Alazragi R; Salem N; Elaidy SM
    Mol Cell Biochem; 2020 Jun; 469(1-2):143-157. PubMed ID: 32356241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
    Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
    Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ajuba: An emerging signal transducer in oncogenesis.
    Jia H; Peng H; Hou Z
    Pharmacol Res; 2020 Jan; 151():104546. PubMed ID: 31740385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The c-MYC-WDR43 signalling axis promotes chemoresistance and tumour growth in colorectal cancer by inhibiting p53 activity.
    Di Y; Jing X; Hu K; Wen X; Ye L; Zhang X; Qin J; Ye J; Lin R; Wang Z; He W
    Drug Resist Updat; 2023 Jan; 66():100909. PubMed ID: 36525936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of DJ-1 enhances colorectal cancer cell proliferation through the cyclin-D1/MDM2-p53 signaling pathway.
    Zhu X; Luo C; Lin K; Bu F; Ye F; Huang C; Luo H; Huang J; Zhu Z
    Biosci Trends; 2020 May; 14(2):83-95. PubMed ID: 32132307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The LIM protein Ajuba recruits DBC1 and CBP/p300 to acetylate ERα and enhances ERα target gene expression in breast cancer cells.
    Xu B; Li Q; Chen N; Zhu C; Meng Q; Ayyanathan K; Qian W; Jia H; Wang J; Ni P; Hou Z
    Nucleic Acids Res; 2019 Mar; 47(5):2322-2335. PubMed ID: 30597111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribosomal L1 domain-containing protein 1 coordinates with HDM2 to negatively regulate p53 in human colorectal Cancer cells.
    Ding L; Zhang Z; Zhao C; Chen L; Chen Z; Zhang J; Liu Y; Nie Y; He Y; Liao K; Zhang X
    J Exp Clin Cancer Res; 2021 Aug; 40(1):245. PubMed ID: 34362424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LIF negatively regulates tumour-suppressor p53 through Stat3/ID1/MDM2 in colorectal cancers.
    Yu H; Yue X; Zhao Y; Li X; Wu L; Zhang C; Liu Z; Lin K; Xu-Monette ZY; Young KH; Liu J; Shen Z; Feng Z; Hu W
    Nat Commun; 2014 Oct; 5():5218. PubMed ID: 25323535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PHD1 regulates p53-mediated colorectal cancer chemoresistance.
    Deschoemaeker S; Di Conza G; Lilla S; Martín-Pérez R; Mennerich D; Boon L; Hendrikx S; Maddocks OD; Marx C; Radhakrishnan P; Prenen H; Schneider M; Myllyharju J; Kietzmann T; Vousden KH; Zanivan S; Mazzone M
    EMBO Mol Med; 2015 Oct; 7(10):1350-65. PubMed ID: 26290450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.